Journal Of Clinical Oncology (jco) Podcast

Expanding Immunotheapy Benefit in Metastatic RCC

Informações:

Synopsis

Discussion of a phase I trial of the checkpoint inhibitor atezolizumab in metastatic renal carcinoma.